A Two-Stage Process for Differentiation of Wharton’s Jelly-Derived Mesenchymal Stem Cells into Neuronal-like Cells
With no permanent cure for neurodegenerative diseases, the symptoms reappear shortly after the withdrawal of medicines. A better treatment outcome can be expected if the damaged neurons are partly replaced by functional neurons and/or they are repaired using trophic factors. In this regard, safe cel...
Saved in:
| Main Authors: | Zaffar Equbal, Prakash N. Baligar, Madhulika Srivastava, Asok Mukhopadhyay |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-01-01
|
| Series: | Stem Cells International |
| Online Access: | http://dx.doi.org/10.1155/2021/6631651 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
COMPARISON OF THE IMMUNOMODULATORY PROPERTIES OF THE CORD BLOOD AND WHARTON’S JELLY DERIVED MESENCHYMAL STEM CELLS
by: Ayşe Erol, et al.
Published: (2023-06-01) -
Biocompatibility Assessment of PLCL-Sericin Copolymer Membranes Using Wharton’s Jelly Mesenchymal Stem Cells
by: Kewalin Inthanon, et al.
Published: (2016-01-01) -
Intrinsic Variability Present in Wharton’s Jelly Mesenchymal Stem Cells and T Cell Responses May Impact Cell Therapy
by: Fernanda Vieira Paladino, et al.
Published: (2017-01-01) -
Osteogenic Induction of Wharton’s Jelly-Derived Mesenchymal Stem Cell for Bone Regeneration: A Systematic Review
by: Ayu Suraya Ansari, et al.
Published: (2018-01-01) -
Inhibition of Cervical Cancer Cell Migration by Human Wharton’s Jelly Stem Cells
by: Snwr Sabir Mohammad, et al.
Published: (2022-05-01)